Back to Results

Transcat Inc (TRNS)

Featured in High-Beta Stocks Small-Cap Stocks

Transcat, Inc. is a common stock listed on NASDAQ under the symbol TRNS. The company provides calibration and laboratory instrument services in the United States, Canada, and international markets, alongside the distribution and rental of test, measurement, and control instruments. Its operations are organized into two segments: Service and Distribution. The Service segment includes calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and related support, as well as software and online tools for workflow, asset management, and record archiving. The Distribution segment sells and rents instrumentation and also provides services such as equipment calibration, certification, rental, used equipment sales, and kitting. Transcat serves regulated industries, including life sciences, aerospace and defense, industrial manufacturing, energy and utilities, and chemical manufacturing. The company was incorporated in 1964 and is headquartered in Rochester, New York.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-TRNS
$75.85
-12.4% Downside
Fair
$101.33
17.0% Upside
Fair
Fair
—
—
—
0.0%
August 4, 2026
150.4x
2.7x
2.4x
804.1 M
937 M
14.2%
97.7%
5.8
—
363.7%
Send a message
Valuation • Fair Value

Transcat Inc (NASDAQ-TRNS) Fair Value by Valuation Model

Compare the primary fair value estimate for Transcat Inc (NASDAQ-TRNS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$75.85

Estimated downside of 12.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$70.25

Discounted cash flow valuation reference.

Ben Graham Formula Value

$6.39

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$81.45

Comparable-company valuation reference.

Analyst Price Target

$101.33

Analysts imply upside of 17.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Transcat Inc (NASDAQ-TRNS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Transcat Inc (NASDAQ-TRNS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

331.9 M

Current operating scale indicator.

Revenue Forecast

362.9 M

Forward revenue estimate.

EBITDA

41.885 M

Current operating profitability reference.

EBITDA Forecast

53.541 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Transcat Inc (NASDAQ-TRNS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Transcat Inc (NASDAQ-TRNS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.81

No elevated caution signal from this screen.

Altman Z-Score

5.8

Relatively strong balance-sheet zone.

FCF / Net Income

363.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Transcat Inc (NASDAQ-TRNS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Transcat Inc (NASDAQ-TRNS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 4, 2026

Days to Earnings

14

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Transcat Inc (NASDAQ-TRNS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Transcat Inc (NASDAQ-TRNS) Stock Forecast & Technical Outlook

Review Transcat Inc (NASDAQ-TRNS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Transcat Inc (NASDAQ-TRNS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Transcat Inc (NASDAQ-TRNS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Transcat Inc (NASDAQ-TRNS) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Transcat Inc (NASDAQ-TRNS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Transcat Inc (NASDAQ-TRNS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Transcat Inc (NASDAQ-TRNS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Transcat Inc (NASDAQ-TRNS) has a Strong Buy consensus, with 3 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 3
Hold 1
Sell 0
FAQ • Fast Investor Answers

Transcat Inc (NASDAQ-TRNS) Stock FAQ

Quick answers about Transcat Inc (NASDAQ-TRNS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$75.85
Estimated downside 12.4%
Valuation Rating
Overvalued
Estimated downside of 12.4%
Analyst Target
$101.33
Implied upside 17.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Transcat Inc (NASDAQ-TRNS) is $75.85. This implies an estimated downside of 12.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 12.4% versus the current market price.

The available analyst price target for Transcat Inc (NASDAQ-TRNS) is $101.33. The analyst target implies estimated upside of 17.0%.

The current financial health read for Transcat Inc (NASDAQ-TRNS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Transcat Inc (NASDAQ-TRNS) is August 4, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Transcat Inc (NASDAQ-TRNS) is 150.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Transcat Inc is 804.1 M.

The current enterprise value listed for Transcat Inc is 937 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Transcat Inc is NASDAQ-TRNS, and the stock is listed on NASDAQ.

Transcat Inc (NASDAQ-TRNS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Transcat Inc is 14.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Transcat Inc is 97.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Trading Companies & Distributors Stocks on NASDAQ View more

Fastenal Company (FAST) Fastenal Company (FAST)
Rush Enterprises A Inc (RUSHA) Rush Enterprises A Inc (RUSHA)
Rush Enterprises B Inc (RUSHB) Rush Enterprises B Inc (RUSHB)
Xometry Inc (XMTR) Xometry Inc (XMTR)
EquipmentShare Com Inc (EQPT) EquipmentShare Com Inc (EQPT)
McGrath RentCorp (MGRC) McGrath RentCorp (MGRC)
DXP Enterprises Inc (DXPE) DXP Enterprises Inc (DXPE)
Distribution Solutions Group Inc (DSGR) Distribution Solutions Group Inc (DSGR)
Willis Lease Finance Corporation (WLFC) Willis Lease Finance Corporation (WLFC)
Karat Packaging Inc (KRT) Karat Packaging Inc (KRT)
Titan Machinery Inc (TITN) Titan Machinery Inc (TITN)
Hudson Technologies Inc (HDSN) Hudson Technologies Inc (HDSN)
Texxon Holding Ltd (NPT) Texxon Holding Ltd (NPT)
Simpple Ltd (SPPL) Simpple Ltd (SPPL)
Marwynn Holdings Inc (MWYN) Marwynn Holdings Inc (MWYN)
Ten League International Hold Ltd (TLIH) Ten League International Hold Ltd (TLIH)
Euro Tech Holdings Company Ltd (CLWT) Euro Tech Holdings Company Ltd (CLWT)
FGI Industries Ltd (FGI) FGI Industries Ltd (FGI)
BioNexus Gene Lab Corp (BGLC) BioNexus Gene Lab Corp (BGLC)
Capstone Holding Corp (CAPS) Capstone Holding Corp (CAPS)
IPower Inc (IPW) IPower Inc (IPW)